47 research outputs found
The algebra of a class of permutation invariant irreducible operators
Available from British Library Document Supply Centre- DSC:D186292 / BLDSC - British Library Document Supply CentreSIGLEGBUnited Kingdo
PErineal Assessment and Repair Longitudinal Study (PEARLS): protocol for a matched pair cluster trial
Background: The Perineal Assessment and Repair Longitudinal Study (PEARLS) is a national clinical quality
improvement initiative designed to improve the assessment and management of perineal trauma. Perineal trauma
affects around 85% of women who have a vaginal birth in the UK each year and millions more world-wide.
Continuous suturing techniques compared with traditional interrupted methods are more effective in reducing
pain and postnatal morbidity, however they are not widely used by clinicians despite recommendations of
evidence based national clinical guidelines. Perineal suturing skills and postnatal management of trauma remain
highly variable within and between maternity units in the UK as well as worldwide. Implementation of a
standardised training package to support effective perineal management practices could reduce perineal pain and
other related postnatal morbidity for a substantial number of women.
Methods/Design: PEARLS is a matched pair cluster trial, which is being conducted in maternity units across the
UK. Units within a matched pair will be randomised to implement the study intervention either early or late in the
study period. The intervention will include the cascading of a multi-professional training package to enhance
midwifery and obstetric skills in the assessment, repair and postnatal management of perineal trauma. Women
who have had an episiotomy or second degree perineal tear will be eligible for recruitment. Prior to developing
the intervention and deciding on study outcomes, a Delphi survey and a consensus conference were held to
identify what women, who previously suffered perineal trauma during childbirth, considered to be important
outcomes for them. Findings from this preliminary work (which will be reported elsewhere) and other outcomes
including womenâs experiences of perineal pain and pain on activity, breastfeeding uptake and duration and
psychological well-being as assessed using the Edinburgh Postnatal Depression Scale (EPDS) will be assessed at 10
days and three months post-birth.
Discussion: Implementation of evidence-based perineal assessment and management practices, could lead to
significantly improved physical and psychological health outcomes for women in the UK and world-wide
Increased CD200 Expression in Acute Myeloid Leukemia is Linked With an Increased Frequency of FoxP3+ Regulatory T Cells
CD200 Inhibits Memory Th1 Cell Function in Acute Myeloid Leukaemia (AML)
CD200 is a cell-surface glycoprotein that is normally expressed in tissues of the immune system, where its role is to protect immune privileged sites. We previously established CD200 to be frequently over-expressed and associated with poor AML patient outcome. In
this study, we investigated the possibility that CD200 expression may mediate suppression of T-cell function in this disease. Using multiparameter flow cytometry, we compared PMA/ionomycin stimulated CD8+ T-cell cytotoxic potential (CD107a expression) and the frequency
of intracellular TNFa, IL-2 and IFNc producing CD4+/CD8+
memory T-cells between CD200hi and CD200lo patients. We demonstrated that both the magnitude of the CD8+ memory cytotoxic T-cell response and the Th1 cytokine producing CD4+ memory helper T-cells was significantly inhibited in CD200hi AML patients (P < 0.05). Further, using ELISPOT assays to measure IFNg release we showed that the Th1 memory response to common viral antigens was significantly reduced by 75% in CD200hi versus CD200lo AML patients(P < 0.05). Recovery of IFNc release in response to recall antigens
was observed in CD4+ memory T-cells incubated with a
blocking antibody to CD200R. In conclusion, this study shows a correlation between T-cell dysfunction and expression of CD200 which suggests targeting this axis could be therapeutically beneficial for AML CD200hi patients
Evaluating sixty years of UK trials research in acute myeloid leukaemia: lessons for trial design, past, present and future
Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials.
Item does not contain fulltextDown syndrome (DS) children are at an increased risk of developing myelodysplasia and acute myeloid leukaemia (AML). We retrospectively analysed the population-based data on 81 children with myeloid leukaemia of Down syndrome (ML-DS) from the UK National Registry of Childhood Tumours and experience in the Medical Research Council (MRC) AML 10 and AML 12 trials, which enrolled 46 children with ML-DS from 1988 to 2002. Eight per cent of UK children with AML had DS, but DS children comprised only 5% of children registered in MRC trials. The unique clinical characteristics of ML-DS were confirmed. Overall survival (OS) of ML-DS at 5 years increased from 47% in UK children diagnosed from 1988 to 1995 to 75% in children diagnosed from 1996 to 2002. OS for DS children registered in AML 10 and AML 12 was 74% in 5 years and improved from AML 10 to AML 12 (56% vs. 83%) There was no significant difference in OS between DS and non-DS children (OS: 74% vs. 62%, P = 0.4) in the trials, but this result masked a significant increase in early death amongst DS children, with a significant reduction in mortality later on. Relapse was significantly reduced (3% vs. 39%, P = 0.0003), leading to the improved disease-free survival (83% vs. 56%, P = 0.02). Given the increased number of early treatment-related deaths, future treatment protocols should aim to reduce chemotherapy dosage or intensity whilst maintaining low rates of resistant and recurrent disease
Better Thermal Calculations Using Modified Generalized Leveque Equations for Chevron Plate Heat Exchangers
Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness
OBJECTIVE: To determine the accuracy, acceptability and cost-effectiveness of polymerase chain reaction (PCR) and optical immunoassay (OIA) rapid tests for maternal group B streptococcal (GBS) colonisation at labour. DESIGN: A test accuracy study was used to determine the accuracy of rapid tests for GBS colonisation of women in labour. Acceptability of testing to participants was evaluated through a questionnaire administered after delivery, and acceptability to staff through focus groups. A decision-analytic model was constructed to assess the cost-effectiveness of various screening strategies. SETTING: Two large obstetric units in the UK. PARTICIPANTS: Women booked for delivery at the participating units other than those electing for a Caesarean delivery. INTERVENTIONS: Vaginal and rectal swabs were obtained at the onset of labour and the results of vaginal and rectal PCR and OIA (index) tests were compared with the reference standard of enriched culture of combined vaginal and rectal swabs. MAIN OUTCOME MEASURES: The accuracy of the index tests, the relative accuracies of tests on vaginal and rectal swabs and whether test accuracy varied according to the presence or absence of maternal risk factors. RESULTS: PCR was significantly more accurate than OIA for the detection of maternal GBS colonisation. Combined vaginal or rectal swab index tests were more sensitive than either test considered individually [combined swab sensitivity for PCR 84% (95% CI 79-88%); vaginal swab 58% (52-64%); rectal swab 71% (66-76%)]. The highest sensitivity for PCR came at the cost of lower specificity [combined specificity 87% (95% CI 85-89%); vaginal swab 92% (90-94%); rectal swab 92% (90-93%)]. The sensitivity and specificity of rapid tests varied according to the presence or absence of maternal risk factors, but not consistently. PCR results were determinants of neonatal GBS colonisation, but maternal risk factors were not. Overall levels of acceptability for rapid testing amongst participants were high. Vaginal swabs were more acceptable than rectal swabs. South Asian women were least likely to have participated in the study and were less happy with the sampling procedure and with the prospect of rapid testing as part of routine care. Midwives were generally positive towards rapid testing but had concerns that it might lead to overtreatment and unnecessary interference in births. Modelling analysis revealed that the most cost-effective strategy was to provide routine intravenous antibiotic prophylaxis (IAP) to all women without screening. Removing this strategy, which is unlikely to be acceptable to most women and midwives, resulted in screening, based on a culture test at 35-37 weeks' gestation, with the provision of antibiotics to all women who screened positive being most cost-effective, assuming that all women in premature labour would receive IAP. The results were sensitive to very small increases in costs and changes in other assumptions. Screening using a rapid test was not cost-effective based on its current sensitivity, specificity and cost. CONCLUSIONS: Neither rapid test was sufficiently accurate to recommend it for routine use in clinical practice. IAP directed by screening with enriched culture at 35-37 weeks' gestation is likely to be the most acceptable cost-effective strategy, although it is premature to suggest the implementation of this strategy at present